Pulse Biosciences, Inc. Deferred Income Tax Expense (Benefit)
Pulse Biosciences, Inc. (PLSE) reported Deferred Income Tax Expense (Benefit) of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2024-03-28
- Pulse Biosciences, Inc. deferred income tax expense (benefit) for the quarter ending 2015-12-31 was -$518.00K.
- Pulse Biosciences, Inc. deferred income tax expense (benefit) for the quarter ending 2015-09-30 was -$483.00K.
- Pulse Biosciences, Inc. deferred income tax expense (benefit) for the quarter ending 2015-06-30 was -$357.00K.
- Pulse Biosciences, Inc. deferred income tax expense (benefit) for the quarter ending 2015-03-31 was -$299.00K.
- Pulse Biosciences, Inc. deferred income tax expense (benefit) for fiscal 2023 was $0.00.
- Pulse Biosciences, Inc. deferred income tax expense (benefit) for fiscal 2022 was $0.00.
- Pulse Biosciences, Inc. deferred income tax expense (benefit) for fiscal 2021 was $0.00.
- Pulse Biosciences, Inc. deferred income tax expense (benefit) for fiscal 2020 was $0.00.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 7 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 | ||||
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 | ||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 | ||||
| 2020-12-31 | $0.00 10-K · filed 2023-03-31 | ||||
| 2015-12-31 | -$518.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$1.00M derived: sum of 2 quarters · filed 2018-03-16 | -$1.36M derived: sum of 3 quarters · filed 2018-03-16 | -$1.66M 10-K · filed 2018-03-16 | |
| 2015-09-30 | -$483.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$840.00K derived: sum of 2 quarters · filed 2016-11-14 | -$1.14M 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | -$357.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | -$656.00K 10-Q · filed 2016-08-10 | |||
| 2015-03-31 | -$299.00K 10-Q · filed 2016-06-27 | ||||
| 2014-12-31 | -$23.00K 10-K · filed 2017-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |